In Canada, South Asian communities are at a higher risk of developing Type 2 diabetes compared to the general population. As a result, South Asian populations experience significant morbidity and mortality.
As a Canadian with Type 1 diabetes I’m dismayed by the way pharmaceutical companies have driven up insulin prices, created a global oligarchy and increased the burden on those who need this life-giving medicine.
Please use the invisible republishing code below on the page where you republish this article.
Please give credit to Healthy Debate and include a link back to our home page or the article URL . Our preference is a credit at the top of the article and that you include our logo (available by clicking the link below).
Please read the full set of instructions for republication here.